Sage Journals: Discover world-class research

Retricted access

Research article

First published 2025-2

DISCOntinuation of disease-modifying therapies in MS: The DISCOMS extension trial

John R Corboy, Robert J Fox, Gary Cutter [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2024

Disease-modifying therapy initiation patterns in multiple sclerosis in three large MS populations

Alexander Stahmann, Elaine Craig, David Ellenberger [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2022-11

Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies

Irene Schiavetti, Cinzia Cordioli, Maria Laura Stromillo [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2024-2

University education facilitates uptake of disease-modifying therapies for multiple sclerosis: A community-based study using the UK MS Register

Joyutpal Das, David J Rog, Rod Middleton [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2024

Treatment switches of disease-modifying therapies in people with multiple sclerosis: long-term experience from the German MS Registry

Niklas Frahm, David Ellenberger, Alexander Stahmann [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Other

First published 2020-2

Real-world studies provide reliable comparisons of disease modifying therapies in MS – No

Maria Pia Sormani

Multiple Sclerosis Journal

Open access

Research article

First published 2023-8

Quality of life should be the primary outcome for disease modifying therapy trials in MS—No

EMM Strijbis, MW Koch, BA de Jong

Multiple Sclerosis Journal

Open access

Research article

First published 2025-5

Safety and tolerability of conversion to siponimod from other disease-modifying therapies in patients with advancing forms of relapsing MS: Results from the EXCHANGE study

Robert J Fox, Stanley Cohan, Yang Mao-Draayer [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2024-8

Significantly increasing multiple sclerosis prevalence in Australia from 2010 to 2021

Julie A Campbell, Steve Simpson-Yap, Bruce V Taylor [...]

Multiple Sclerosis Journal

Retricted access

Other

First published 2020-2

Real-world studies provide reliable comparisons of disease modifying therapies in MS – Commentary

Fred Lublin

Multiple Sclerosis Journal

Search results